The role of activin in mammary gland development and oncogenesis (Q37863042)

24 August 2017

1 reference

title

The role of activin in mammary gland development and oncogenesis (English)

1 reference

24 August 2017

Karen A Dunphy

1 reference

24 August 2017

Alan L Schneyer

series ordinal

1 reference

24 August 2017

Mary J Hagen

series ordinal

1 reference

24 August 2017

D Joseph Jerry

series ordinal

1 reference

24 August 2017

language of work or name

1 reference

8 April 2011

1 reference

Journal of Mammary Gland Biology and Neoplasia

24 August 2017

published in

1 reference

24 August 2017

1 reference

24 August 2017

1 reference

24 August 2017

page(s)

117-126

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

24 August 2017

1 reference

Roles of TGFbeta in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

TGF-beta and epithelial-to-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Beta A versus beta B: is it merely a matter of expression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Activins and activin antagonists in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Betaglycan binds inhibin and can mediate functional antagonism of activin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Betaglycan presents ligand to the TGF beta signaling receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Antagonists of activin signaling: mechanisms and potential biological applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Characterization of unique binding kinetics of follistatin and activin or inhibin in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Differential Binding and Neutralization of Activins A and B by Follistatin and Follistatin Like-3 (FSTL-3/FSRP/FLRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

FLRG, an activin-binding protein, is a new target of TGFbeta transcription activation through Smad proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Differential expression of TGF-beta isoforms during postlactational mammary gland involution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Reversible inhibition of mammary gland growth by transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Transgenic Mice Expressing a Dominant-Negative Mutant Type II Transforming Growth Factor-β Receptor Exhibit Impaired Mammary Development and Enhanced Mammary Tumor Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

TGF-beta 1-induced inhibition of mouse mammary ductal growth: developmental specificity and characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Transforming growth factor-beta inhibits lactogenic hormone induction of beta-casein expression in HC11 mouse mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

TGF beta suppresses casein synthesis in mouse mammary explants and may play a role in controlling milk levels during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Localization of activin and inhibin subunits, receptors and SMADs in the mouse mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Activin and follistatin in rat mammary gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Activin, inhibin and the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Identification of activin A and follistatin in human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Cripto: a tumor growth factor and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Activins as regulators of branching morphogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Abrogation of Smad3 and Smad2 or of Smad4 gene expression positively regulates murine embryonic lung branching morphogenesis in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Mouse strain-specific patterns of mammary epithelial ductal side branching are elicited by stromal factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Transforming growth factor-beta and breast cancer: Mammary gland development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

TGF-beta signaling in tumor suppression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

TGF-beta signaling: positive and negative effects on tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Mammary tumor suppression by transforming growth factor beta 1 transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Proliferation of estrogen receptor-alpha-positive mammary epithelial cells is restrained by transforming growth factor-beta1 in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Activin and estrogen crosstalk regulates transcription in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

TGF-beta superfamily members, ActivinA and TGF-beta1, induce apoptosis in oligodendrocytes by different pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Activin inhibits telomerase activity in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Uses of telomerase peptides in anti-tumor immune therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Targeting the TGF beta signaling network in human neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Activins and inhibins in endocrine and other tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Identification and characterization of human ARIP2 and its relation to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Obesity and women's health: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Associations of insulin resistance and adiponectin with mortality in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Insulin breast cancer connection: confirmatory data set the stage for better care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Activin signaling as an emerging target for therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Activin signaling: effects on body composition and mitochondrial energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Emerging roles for the TGFbeta family in pancreatic beta-cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Pregnancy and breast cancer: when they collide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Pregnancy-associated breast cancer and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Transforming growth factor-(beta)s and mammary gland involution; functional roles and implications for cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Preeclampsia and Breast Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9214-4

Follistatin and its role as an activin-binding protein.

21 January 2018

1 reference

12 December 2020

Transforming growth factor beta signaling through Smad1 in human breast cancer cells

1 reference

12 December 2020

Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells

1 reference

12 December 2020

Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice

1 reference

12 December 2020

Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy

1 reference

12 December 2020

Abnormal concentration of maternal serum activin-A in gestational diseases

1 reference

12 December 2020

1 reference

12 December 2020

Effects of estrogen on global gene expression: identification of novel targets of estrogen action

1 reference

12 December 2020

Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development

1 reference

12 December 2020

Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure

1 reference

12 December 2020

Novel factors in regulation of activin signaling

1 reference

12 December 2020

Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: evidence for a secretion into cystic fluid

1 reference

12 December 2020

Apoptotic cell death and tissue remodelling during mouse mammary gland involution

1 reference

12 December 2020

Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution.

1 reference

12 December 2020

Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-beta-dependent pathways

1 reference

12 December 2020

Serum and tissue expression of activin a in postmenopausal women with breast cancer

1 reference

12 December 2020

Silencing of FLRG, an Antagonist of Activin, Inhibits Human Breast Tumor Cell Growth

1 reference

12 December 2020

Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation.

1 reference

12 December 2020

Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions

1 reference

12 December 2020

Preeclampsia and breast cancer risk

1 reference

12 December 2020

Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis

1 reference

12 December 2020

Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression.

1 reference

12 December 2020

Transforming growth factor-beta1 mediates cellular response to DNA damage in situ.

1 reference

12 December 2020

Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines.

1 reference

12 December 2020

Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer.

1 reference

12 December 2020

Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells

1 reference

12 December 2020

10.1007/S10911-011-9214-4

Identifiers

DOI

1 reference

24 August 2017

1 reference